Arcellx (ACLX) Cash from Investing Activities (2021 - 2025)

Arcellx's quarterly Cash from Investing Activities came in at $57.8 million in Q4 2025, up 1502.86% year-on-year from $3.6 million in Q4 2024, and up 388.61% quarter-over-quarter from -$20.0 million in Q3 2025.

Arcellx has reported Cash from Investing Activities for 5 years, with the latest figure at $57.8 million in Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities rose 1502.86% year-over-year to $57.8 million; the trailing twelve-month figure through Dec 2025 stood at $86.3 million (up 147.15% YoY), and the FY2025 full-year result was $86.3 million, up 147.15% from the prior year.
  • Cash from Investing Activities for Q4 2025 stood at $57.8 million, up from -$20.0 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $57.8 million in Q4 2025, with the low at -$206.8 million in Q1 2024.
  • Average Cash from Investing Activities over 5 years is -$22.4 million, with a median of -$6.0 million recorded in 2024.
  • Year-over-year, Cash from Investing Activities sank 32807.22% in 2022 and surged 1502.86% in 2025.
  • Tracing ACLX's Cash from Investing Activities over 5 years: stood at -$17.7 million in 2021, then surged by 290.35% to $33.6 million in 2022, then tumbled by 37.49% to $21.0 million in 2023, then plunged by 119.6% to -$4.1 million in 2024, then soared by 1502.86% to $57.8 million in 2025.
  • The last three Cash from Investing Activities figures came in at $57.8 million (Q4 2025), -$20.0 million (Q3 2025), and $10.7 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -2.89 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 638.50 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -431.90 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -428.90 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -25.54 Mn
10 Arcellx 6.48 Bn 6.48 Bn - 57.80 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 57.80 Mn
Dec 31, 2025 57.80 Mn
Sep 30, 2025 -20.03 Mn
Sep 30, 2025 -20.03 Mn
Jun 30, 2025 10.74 Mn
Jun 30, 2025 10.74 Mn
Mar 31, 2025 37.78 Mn
Mar 31, 2025 37.78 Mn
Dec 31, 2024 -4.12 Mn
Dec 31, 2024 -4.12 Mn
Sep 30, 2024 35.76 Mn
Sep 30, 2024 35.76 Mn
Jun 30, 2024 -7.87 Mn
Jun 30, 2024 -7.87 Mn
Mar 31, 2024 -206.81 Mn
Mar 31, 2024 -206.81 Mn
Dec 31, 2023 21.02 Mn
Dec 31, 2023 21.02 Mn
Sep 30, 2023 -160.03 Mn
Sep 30, 2023 -160.03 Mn
Jun 30, 2023 51.27 Mn
Jun 30, 2023 51.27 Mn
Mar 31, 2023 -66.77 Mn
Mar 31, 2023 -66.77 Mn
Dec 31, 2022 33.62 Mn
Dec 31, 2022 33.62 Mn
Sep 30, 2022 -81.42 Mn
Sep 30, 2022 -81.42 Mn
Jun 30, 2022 -59.23 Mn
Jun 30, 2022 -59.23 Mn
Mar 31, 2022 -10.64 Mn
Mar 31, 2022 -10.64 Mn
Dec 31, 2021 -17.66 Mn
Dec 31, 2021 -17.66 Mn
Sep 30, 2021 -61.07 Mn
Sep 30, 2021 -61.07 Mn
Jun 30, 2021 -180,000.00
Jun 30, 2021 -180,000.00
Mar 31, 2021 -1.07 Mn
Mar 31, 2021 -1.07 Mn